This has somewhat already been solved.  Avastin works really well for colorectal cancer, so it was tried in a really small trial in breast cancer.  There was a small signal there, so the FDA gave conditional approval with the agreement that the company would run a larger test to confirm the results.<p>Well, they ran the bigger trial and it showed no benefit at all.  The FDA rescinded conditional approval.